Adaptimmune Therapeutics shares owned by Geode Capital Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.7k | 67k | 0.13 |
| 2025-06-30 | $16k | 67k | 0.24 |
| 2025-03-31 | $22k | 109k | 0.20 |
| 2024-12-31 | $75k | 140k | 0.54 |
| 2024-09-30 | $133k | 140k | 0.95 |
| 2024-06-30 | $115k | 118k | 0.97 |
| 2024-03-31 | $186k | 118k | 1.58 |
| 2023-09-30 | $92k | 118k | 0.78 |
| 2023-06-30 | $109k | 118k | 0.93 |
| 2023-03-31 | $115k | 106k | 1.09 |
| 2022-12-31 | $154k | 106k | 1.45 |
| 2022-09-30 | $78k | 73k | 1.07 |
| 2022-06-30 | $123k | 73k | 1.69 |
| 2022-03-31 | $149k | 73k | 2.05 |
| 2021-12-31 | $272k | 73k | 3.74 |
| 2021-09-30 | $376k | 73k | 5.17 |
| 2021-06-30 | $309k | 73k | 4.25 |
| 2021-03-31 | $386k | 73k | 5.30 |
| 2020-12-31 | $265k | 49k | 5.39 |
| 2020-09-30 | $883k | 111k | 7.98 |
| 2020-06-30 | $610k | 61k | 10.01 |
| 2020-03-31 | $139k | 51k | 2.70 |
| 2019-12-31 | $117k | 98k | 1.19 |
| 2019-09-30 | $96k | 64k | 1.50 |
| 2019-06-30 | $257k | 64k | 4.02 |
| 2019-03-31 | $275k | 64k | 4.30 |
| 2018-12-31 | $225k | 39k | 5.73 |
| 2018-09-30 | $537k | 40k | 13.55 |
| 2018-06-30 | $488k | 41k | 11.85 |
| 2018-03-31 | $485k | 43k | 11.23 |
| 2017-12-31 | $0 | 29k | 0.00 |
| 2017-09-30 | $234k | 29k | 8.18 |
| 2017-06-30 | $128k | 29k | 4.47 |
| 2017-03-31 | $92k | 17k | 5.46 |
| 2016-12-31 | $66k | 16k | 4.02 |
| 2016-09-30 | $113k | 16k | 7.00 |
| 2016-06-30 | $83k | 10k | 8.08 |